Analysis of Methylation Patterns and Expression Profiles of P14 Arf Gene in Patients with Oral Squamous Cell Carcinoma

World Health Organization. The World Health Report 2004 – Changing History. Geneva: WHO, 2004.

Mousavi S.M. , Gouya M.M. , Ramazani R. , Davanlou M. , Hajsadeghi N. , Seddighi Z. Cancer incidence and mortality in Iran. Ann Oncol 2009; 20: 556–63.

Petersen P.E. Oral cancer prevention and control–the approach of the World Health Organization. Oral Oncol 2009; 45: 454–60.

Feinberg A.P. , Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983; 301: 89–92.

Ding Z. , Qian Yb , Zhu Lx , xiong Q.R. Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma. World J Gastroenterol 2009; 15: 2595–601.

Ruas M. , Peters G. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1998; 1378: F115–77.

Serrano M. , Hannon G.J. , Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366: 704–7.

Sherr C.J. , Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995; 9: 1149–63.

Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell 1995; 81: 323–30.

Kamijo T. , Weber J.D. , Zambetti G. , Zindy F. , Roussel M.F. , Sherr C.J. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc Natl Acad Sci U S A 1998; 95: 8292–7.

Kamijo T. , Zindy F. , Roussel M.F. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 1997; 91: 649–59.

Berggren P. , Kumar R. , Sakano S. Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR. Clin Cancer Res 2003; 9: 235–42.

Esteller M. , Tortola S. , Toyota M. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res 2000; 60: 129–33.

Sato F. , Harpaz N. , Shibata D. Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis. Cancer Res 2002; 62: 1148–51.

Kang M.Y. , Lee B.B. , Ji Y.I. Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer. Cancer 2008; 112: 1699–707.

Uhrinova S. , Uhrin D. , Powers H. Structure of free MDM2 N-terminal domain reveals conformational adjustments that accompany p53-binding. J Mol Biol 2005; 350: 587–98.

De Jong W.K. , Verpooten G.F. , Kramer H. , Louwagie J. , Groen H.J. Promoter methylation primarily occurs in tumor cells of patients with non-small cell lung cancer. Anticancer Res 2009; 29: 363–9.

Ellinger J. , Albers P. , Perabo F.G. , Muller S.C. , Von Ruecker A. , Bastian P.J. CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer. J Urol 2009; 182: 324–9.

Kuo L.T. , Kuo K.T. , Lee M.J. Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors. Int J Cancer 2009; 124: 2872–9.

Phé V. , Cussenot O. , Rouprêt M. Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract. BJU Int 2009, June 12 [Epub ahead of print].

Tahara T. , Shibata T. , Arisawa T. Impact of catechol-O-methyltransferase (COMT) gene polymorphism on promoter methylation status in gastric mucosa. Anticancer Res 2009; 29: 2857–61.

Sharma G. , Mirza S. , Prasad C.P. , Srivastava A. , Gupta S.D. , Ralhan R. Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients. Life Sci 2007; 80: 1873–81.

Sailasree R. , Abhilash A. , Sathyan K.M. , Nalinakumari K.R. , Thomas S. , Kannan S. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma. Cancer Epidemiol Biomarkers Prev 2008; 17: 414–20.